Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Caroline M. KEATING |
Documents disponibles écrits par cet auteur (2)
Faire une suggestion Affiner la recherche
Adult Outcomes in Autism: Community Inclusion and Living Skills / Kylie M. GRAY in Journal of Autism and Developmental Disorders, 44-12 (December 2014)
[article]
Titre : Adult Outcomes in Autism: Community Inclusion and Living Skills Type de document : Texte imprimé et/ou numérique Auteurs : Kylie M. GRAY, Auteur ; Caroline M. KEATING, Auteur ; John R. TAFFE, Auteur ; Avril V. BRERETON, Auteur ; Stewart L. EINFELD, Auteur ; Tessa C. REARDON, Auteur ; Bruce J. TONGE, Auteur Article en page(s) : p.3006-3015 Langues : Anglais (eng) Mots-clés : Autism Community inclusion Living skills Adult outcomes Index. décimale : PER Périodiques Résumé : Longitudinal research has demonstrated that social outcomes for adults with autism are restricted, particularly in terms of employment and living arrangements. However, understanding of individual and environmental factors that influence these outcomes is far from complete. This longitudinal study followed a community sample of children and adolescents with autism into adulthood. Social outcomes in relation to community inclusion and living skills were examined, including the predictive role of a range of individual factors and the environment (socio-economic disadvantage). Overall, the degree of community inclusion and living skills was restricted for the majority, and while childhood IQ was an important determinant of these outcomes, it was not the sole predictor. The implications of these findings in relation to interventions are discussed. En ligne : http://dx.doi.org/10.1007/s10803-014-2159-x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=243
in Journal of Autism and Developmental Disorders > 44-12 (December 2014) . - p.3006-3015[article] Adult Outcomes in Autism: Community Inclusion and Living Skills [Texte imprimé et/ou numérique] / Kylie M. GRAY, Auteur ; Caroline M. KEATING, Auteur ; John R. TAFFE, Auteur ; Avril V. BRERETON, Auteur ; Stewart L. EINFELD, Auteur ; Tessa C. REARDON, Auteur ; Bruce J. TONGE, Auteur . - p.3006-3015.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 44-12 (December 2014) . - p.3006-3015
Mots-clés : Autism Community inclusion Living skills Adult outcomes Index. décimale : PER Périodiques Résumé : Longitudinal research has demonstrated that social outcomes for adults with autism are restricted, particularly in terms of employment and living arrangements. However, understanding of individual and environmental factors that influence these outcomes is far from complete. This longitudinal study followed a community sample of children and adolescents with autism into adulthood. Social outcomes in relation to community inclusion and living skills were examined, including the predictive role of a range of individual factors and the environment (socio-economic disadvantage). Overall, the degree of community inclusion and living skills was restricted for the majority, and while childhood IQ was an important determinant of these outcomes, it was not the sole predictor. The implications of these findings in relation to interventions are discussed. En ligne : http://dx.doi.org/10.1007/s10803-014-2159-x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=243 The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial / Adam J. GUASTELLA in Journal of Child Psychology and Psychiatry, 56-4 (April 2015)
[article]
Titre : The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial Type de document : Texte imprimé et/ou numérique Auteurs : Adam J. GUASTELLA, Auteur ; Kylie M. GRAY, Auteur ; Nicole J. RINEHART, Auteur ; Gail A. ALVARES, Auteur ; Bruce J. TONGE, Auteur ; Ian B. HICKIE, Auteur ; Caroline M. KEATING, Auteur ; Cristina CACCIOTTI-SAIJA, Auteur ; Stewart L. EINFELD, Auteur Article en page(s) : p.444-452 Langues : Anglais (eng) Mots-clés : Social cognition neuropeptides developmental disorder emotion recognition placebo-controlled Index. décimale : PER Périodiques Résumé : Background There is increasing interest in oxytocin as a therapeutic to treat social deficits in autism spectrum disorders (ASD). The aim of this study was to investigate the efficacy of a course of oxytocin nasal spray to improve social behavior in youth with ASD. Methods In a double-blind, placebo-controlled trial across two Australian university sites between February 2009 and January 2012, 50 male participants aged between 12 and 18 years, with Autistic or Asperger's Disorder, were randomized to receive either oxytocin (n = 26) or placebo (n = 24) nasal sprays (either 18 or 24 International Units), administered twice-daily for 8 weeks. Participants were assessed at baseline, after 4- and 8-weeks of treatment, and at 3-month follow-up. Primary outcomes were change in total scores on the caregiver-completed Social Responsiveness Scale and clinician-ratings on the Clinical Global Impressions-Improvement scale. Secondary assessments included caregiver reports of repetitive and other developmental behaviors and social cognition. Clinical trial registration: Australian New Zealand Clinical Trials Registry www.anzctr.org.au ACTRN12609000513213. Results Participants who received oxytocin showed no benefit following treatment on primary or secondary outcomes. However, caregivers who believed their children received oxytocin reported greater improvements compared to caregivers who believed their child received placebo. Nasal sprays were well tolerated and there was no evidence of increased side effects resulting from oxytocin administration. Conclusions This is the first evaluation of the efficacy for a course of oxytocin treatment for youth with ASD. Although results did not suggest clinical efficacy, further research is needed to explore alternative delivery methods, earlier age of intervention, and the influence of caregiver expectation on treatment response. En ligne : http://dx.doi.org/10.1111/jcpp.12305 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=260
in Journal of Child Psychology and Psychiatry > 56-4 (April 2015) . - p.444-452[article] The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial [Texte imprimé et/ou numérique] / Adam J. GUASTELLA, Auteur ; Kylie M. GRAY, Auteur ; Nicole J. RINEHART, Auteur ; Gail A. ALVARES, Auteur ; Bruce J. TONGE, Auteur ; Ian B. HICKIE, Auteur ; Caroline M. KEATING, Auteur ; Cristina CACCIOTTI-SAIJA, Auteur ; Stewart L. EINFELD, Auteur . - p.444-452.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 56-4 (April 2015) . - p.444-452
Mots-clés : Social cognition neuropeptides developmental disorder emotion recognition placebo-controlled Index. décimale : PER Périodiques Résumé : Background There is increasing interest in oxytocin as a therapeutic to treat social deficits in autism spectrum disorders (ASD). The aim of this study was to investigate the efficacy of a course of oxytocin nasal spray to improve social behavior in youth with ASD. Methods In a double-blind, placebo-controlled trial across two Australian university sites between February 2009 and January 2012, 50 male participants aged between 12 and 18 years, with Autistic or Asperger's Disorder, were randomized to receive either oxytocin (n = 26) or placebo (n = 24) nasal sprays (either 18 or 24 International Units), administered twice-daily for 8 weeks. Participants were assessed at baseline, after 4- and 8-weeks of treatment, and at 3-month follow-up. Primary outcomes were change in total scores on the caregiver-completed Social Responsiveness Scale and clinician-ratings on the Clinical Global Impressions-Improvement scale. Secondary assessments included caregiver reports of repetitive and other developmental behaviors and social cognition. Clinical trial registration: Australian New Zealand Clinical Trials Registry www.anzctr.org.au ACTRN12609000513213. Results Participants who received oxytocin showed no benefit following treatment on primary or secondary outcomes. However, caregivers who believed their children received oxytocin reported greater improvements compared to caregivers who believed their child received placebo. Nasal sprays were well tolerated and there was no evidence of increased side effects resulting from oxytocin administration. Conclusions This is the first evaluation of the efficacy for a course of oxytocin treatment for youth with ASD. Although results did not suggest clinical efficacy, further research is needed to explore alternative delivery methods, earlier age of intervention, and the influence of caregiver expectation on treatment response. En ligne : http://dx.doi.org/10.1111/jcpp.12305 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=260